BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 12543902)

  • 1. Invasive urothelial carcinoma after exposure to Chinese herbal medicine containing aristolochic acid may occur without severe renal failure.
    Nortier JL; Schmeiser HH; Muniz Martinez MC; Arlt VM; Vervaet C; Garbar CH; Daelemans P; Vanherweghem JL
    Nephrol Dial Transplant; 2003 Feb; 18(2):426-8. PubMed ID: 12543902
    [No Abstract]   [Full Text] [Related]  

  • 2. Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes.
    Chen CH; Dickman KG; Huang CY; Moriya M; Shun CT; Tai HC; Huang KH; Wang SM; Lee YJ; Grollman AP; Pu YS
    Int J Cancer; 2013 Jul; 133(1):14-20. PubMed ID: 23292929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Martinez MC; Schmeiser HH; Arlt VM; Bieler CA; Petein M; Depierreux MF; De Pauw L; Abramowicz D; Vereerstraeten P; Vanherweghem JL
    N Engl J Med; 2000 Jun; 342(23):1686-92. PubMed ID: 10841870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid.
    Jelaković B; Karanović S; Vuković-Lela I; Miller F; Edwards KL; Nikolić J; Tomić K; Slade N; Brdar B; Turesky RJ; Stipančić Ž; Dittrich D; Grollman AP; Dickman KG
    Kidney Int; 2012 Mar; 81(6):559-67. PubMed ID: 22071594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aristolochic acid mutational signature defines the low-risk subtype in upper tract urothelial carcinoma.
    Lu H; Liang Y; Guan B; Shi Y; Gong Y; Li J; Kong W; Liu J; Fang D; Liu L; He Q; Shakeel M; Li X; Zhou L; Ci W
    Theranostics; 2020; 10(10):4323-4333. PubMed ID: 32292497
    [No Abstract]   [Full Text] [Related]  

  • 6. [Aristolochic acid nephropathy ("Chinese herb nephropathy")].
    Nortier J; Pozdzik A; Roumeguere T; Vanherweghem JL
    Nephrol Ther; 2015 Dec; 11(7):574-88. PubMed ID: 26515658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chinese herbs and urothelial carcinoma.
    Li YM
    N Engl J Med; 2000 Oct; 343(17):1269; author reply 1269-70. PubMed ID: 11183354
    [No Abstract]   [Full Text] [Related]  

  • 8. Chinese herbs containing aristolochic acid associated with renal failure and urothelial carcinoma: a review from epidemiologic observations to causal inference.
    Yang HY; Chen PC; Wang JD
    Biomed Res Int; 2014; 2014():569325. PubMed ID: 25431765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chinese herbs and urothelial carcinoma.
    Lu W; Lu W
    N Engl J Med; 2000 Oct; 343(17):1269; author reply 1269-70. PubMed ID: 11183353
    [No Abstract]   [Full Text] [Related]  

  • 10. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy.
    De Broe ME
    Kidney Int; 2012 Mar; 81(6):513-5. PubMed ID: 22373701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re: Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Su YC; Lin JS; Lee MT; Li TC; Lee SM
    J Natl Cancer Inst; 2010 Jul; 102(13):988; author reply 988-90. PubMed ID: 20479292
    [No Abstract]   [Full Text] [Related]  

  • 12. Aristolochic acid and its effect on different cancers in uro-oncology.
    Rebhan K; Ertl IE; Shariat SF; Grollman AP; Rosenquist T
    Curr Opin Urol; 2020 Sep; 30(5):689-695. PubMed ID: 32701724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chinese herbs and urothelial carcinoma.
    Shum S
    N Engl J Med; 2000 Oct; 343(17):1268-9; author reply 1269-70. PubMed ID: 11183352
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased risk of urinary tract cancer in ESRD patients associated with usage of Chinese herbal products suspected of containing aristolochic acid.
    Wang SM; Lai MN; Wei A; Chen YY; Pu YS; Chen PC; Wang JD
    PLoS One; 2014; 9(8):e105218. PubMed ID: 25170766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific detection of aristolochic acid-DNA adducts in the human p53 gene by terminal transferase-dependent PCR.
    Arlt VM; Schmeiser HH; Pfeifer GP
    Carcinogenesis; 2001 Jan; 22(1):133-40. PubMed ID: 11159751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk.
    Lai MN; Wang SM; Chen PC; Chen YY; Wang JD
    J Natl Cancer Inst; 2010 Feb; 102(3):179-86. PubMed ID: 20026811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aristolochic acid-associated urothelial cancer in Taiwan.
    Chen CH; Dickman KG; Moriya M; Zavadil J; Sidorenko VS; Edwards KL; Gnatenko DV; Wu L; Turesky RJ; Wu XR; Pu YS; Grollman AP
    Proc Natl Acad Sci U S A; 2012 May; 109(21):8241-6. PubMed ID: 22493262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer and herbs.
    Kessler DA
    N Engl J Med; 2000 Jun; 342(23):1742-3. PubMed ID: 10841878
    [No Abstract]   [Full Text] [Related]  

  • 19. Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists.
    Yang HY; Wang JD; Lo TC; Chen PC
    J Urol; 2013 Jan; 189(1):48-52. PubMed ID: 23164394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal interstitial fibrosis and urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
    Nortier JL; Vanherweghem JL
    Toxicology; 2002 Dec; 181-182():577-80. PubMed ID: 12505369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.